tiprankstipranks
Captor Therapeutics SA (PL:CTX)
:CTX
Poland Market
CTX
Captor Therapeutics SA
RESEARCH TOOLSreports
Want to see PL:CTX full AI Analyst Report?

Captor Therapeutics SA (CTX) Ratios

1 Followers

Captor Therapeutics SA Ratios

PL:CTX's free cash flow for Q4 2025 was zł-17.84. For the 2025 fiscal year, PL:CTX's free cash flow was decreased by zł and operating cash flow was zł-279.61. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 ― 2.27 3.90 3.32 7.57
Quick Ratio
 ― 2.27 3.90 3.32 7.57
Cash Ratio
 ― 0.72 1.96 2.83 5.30
Solvency Ratio
 ― -2.27 -1.45 -2.32 -1.73
Operating Cash Flow Ratio
 ― -2.44 -1.58 -1.95 -1.71
Short-Term Operating Cash Flow Coverage
 ― -17.62 -11.52 -20.63 -6.17
Net Current Asset Value
zł ―zł 17.28Mzł 55.06Mzł 60.57Mzł 84.65M
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.09 0.06 0.04 0.06
Debt-to-Equity Ratio
 ― 0.15 0.09 0.05 0.07
Debt-to-Capital Ratio
 ― 0.13 0.08 0.05 0.07
Long-Term Debt-to-Capital Ratio
 ― 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 ― 1.70 1.36 1.41 1.17
Debt Service Coverage Ratio
 ― -20.84 -10.34 -22.71 -6.57
Interest Coverage Ratio
 ― -188.01 -102.43 -226.06 -66.26
Debt to Market Cap
 ― <0.01 0.01 <0.01 <0.01
Interest Debt Per Share
 ― 0.70 1.30 0.88 1.81
Net Debt to EBITDA
 ― 0.15 1.02 1.11 2.27
Profitability Margins
Gross Profit Margin
―-13.99%40.59%52.28%77.21%
EBIT Margin
―-1141.78%-240.06%-532.22%-385.62%
EBITDA Margin
―-1048.05%-208.09%-490.60%-308.16%
Operating Profit Margin
―-1141.78%-282.84%-553.11%-418.91%
Pretax Profit Margin
―-901.22%-242.82%-534.25%-391.94%
Net Profit Margin
―-901.22%-242.82%-534.69%-391.94%
Continuous Operations Profit Margin
―-901.22%-242.82%-534.69%-391.94%
Net Income Per EBT
―100.00%100.00%100.08%100.00%
EBT Per EBIT
―78.93%85.85%96.59%93.56%
Return on Assets (ROA)
―-104.93%-43.92%-72.55%-31.76%
Return on Equity (ROE)
―-178.86%-59.60%-101.97%-37.26%
Return on Capital Employed (ROCE)
―-211.89%-66.34%-103.48%-38.51%
Return on Invested Capital (ROIC)
―-195.82%-61.35%-96.55%-35.84%
Return on Tangible Assets
―-108.12%-44.13%-72.78%-31.99%
Earnings Yield
―-10.57%-19.50%-15.19%-5.38%
Efficiency Ratios
Receivables Turnover
 ― 3.84 0.41 1.05 0.95
Payables Turnover
 ― 2.09 3.55 0.97 0.49
Inventory Turnover
 ― 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 ― 0.95 1.79 1.63 0.86
Asset Turnover
 ― 0.12 0.18 0.14 0.08
Working Capital Turnover Ratio
 ― 0.12 0.26 0.18 0.09
Cash Conversion Cycle
 ― -79.71 779.48 -29.24 -365.96
Days of Sales Outstanding
 ― 95.17 882.32 347.53 385.73
Days of Inventory Outstanding
 ― 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 ― 174.87 102.84 376.76 751.69
Operating Cycle
 ― 95.17 882.32 347.53 385.73
Cash Flow Ratios
Operating Cash Flow Per Share
 ― -6.58 -6.79 -11.24 -5.51
Free Cash Flow Per Share
 ― -6.62 -6.88 -11.88 -5.72
CapEx Per Share
 ― 0.04 0.09 0.65 0.21
Free Cash Flow to Operating Cash Flow
 ― 1.01 1.01 1.06 1.04
Dividend Paid and CapEx Coverage Ratio
 ― -172.94 -74.62 -17.37 -25.73
Capital Expenditure Coverage Ratio
 ― -172.94 -74.62 -17.37 -25.73
Operating Cash Flow Coverage Ratio
 ― -10.16 -5.61 -13.82 -3.30
Operating Cash Flow to Sales Ratio
 ― -7.79 -2.00 -3.95 -2.51
Free Cash Flow Yield
―-9.19%-16.27%-11.88%-3.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― -9.46 -5.13 -6.58 -18.58
Price-to-Sales (P/S) Ratio
 ― 85.26 12.45 35.19 72.82
Price-to-Book (P/B) Ratio
 ― 16.92 3.06 6.71 6.92
Price-to-Free Cash Flow (P/FCF) Ratio
 ― -10.88 -6.15 -8.41 -27.97
Price-to-Operating Cash Flow Ratio
 ― -10.94 -6.23 -8.90 -29.06
Price-to-Earnings Growth (PEG) Ratio
 ― 1.22 0.11 -0.09 -2.04
Price-to-Fair Value
 ― 16.92 3.06 6.71 6.92
Enterprise Value Multiple
 ― -7.99 -4.96 -6.06 -21.36
Enterprise Value
 ― 390.15M 163.48M 392.65M 602.82M
EV to EBITDA
 ― -7.99 -4.96 -6.06 -21.36
EV to Sales
 ― 83.72 10.33 29.74 65.82
EV to Free Cash Flow
 ― -10.68 -5.10 -7.11 -25.29
EV to Operating Cash Flow
 ― -10.74 -5.17 -7.52 -26.27
Tangible Book Value Per Share
 ― 4.04 13.75 14.83 22.92
Shareholders’ Equity Per Share
 ― 4.26 13.84 14.90 23.11
Tax and Other Ratios
Effective Tax Rate
 ― 0.00 0.00 >-0.01 0.00
Revenue Per Share
 ― 0.84 3.40 2.84 2.20
Net Income Per Share
 ― -7.61 -8.25 -15.19 -8.61
Tax Burden
 ― 1.00 1.00 1.00 1.00
Interest Burden
 ― 0.79 1.01 1.00 1.02
Research & Development to Revenue
 ― 9.20 2.19 4.91 4.82
SG&A to Revenue
 ― 2.08 1.04 1.22 2.14
Stock-Based Compensation to Revenue
 ― 0.00 0.13 0.35 0.87
Income Quality
 ― 0.86 0.82 0.74 0.64
Currency in PLN